Abstract
Overwhelming evidence that relationships between universities, physicians and the medical products industry benefit patients explains the ubiquitous calls to encourage such relationships. Yet accumulating 'conflict of interest' regulations in academic health centers, government and industry have had the opposite effect. Justifications underlying the regulations lack quantitative rigor, and the rules they enforce impose costly bureaucratic requirements of dubious benefit. Evidence shows that they have diminished the collaborations deemed beneficial to health enhancement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rothman, K.J. J. Am. Med. Assoc. 269, 2782–2784 (1993).
Stossel, T.P. Perspect. Biol. Med. 50, 54–71 (2007).
Campbell, E.G. et al. N. Engl. J. Med. 356, 1742–1750 (2007).
Stossel, T.P. N. Engl. J. Med. 353, 1060–1065 (2005).
Kawczak, S., Carey, W., Lopez, R. & Jackman, D. Acad. Med. 85, 80–84 (2010).
Zycher, B., DiMasi, J. & Milne, C. Am. J. Ther. 17, 101–120 (2010).
Stell, L.K. J. Law Med. Ethics 37, 431–443 (2009).
Osborn, J.E. Yale J. Health Policy Law Ethics 10, 299–356 (2010).
Silverglate, H. Three Felonies a Day: How the Feds Target the Innocent. Ch. 3 (Encounter Books, 2009).
Accreditation Council for Continuing Medical Education. Annual Report. http://www.accme.org/dir_docs/doc_upload/f2e89864-b4c1-428f-8ebe-1ba197a31928_uploaddocument.pdf (2009).
Healy, W.L. & Peterson, R. J. Bone Joint Surg. Am. 91, 1791–1805 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T.P.S. is a founding scientist, director and consultant to Bioaegis Therapeutics, a startup biotechnology company developing intellectual property licensed by his employer, Brigham and Women's Hospital, based on his research. He is also a director of Velico Medical Corporation, to which Brigham and Women's Hospital has also licensed intellectual property based on his research. He serves on a Merck, Sharp and Dohme advisory board.
Rights and permissions
About this article
Cite this article
Stossel, T., Stell, L. Time to 'walk the walk' about industry ties to enhance health. Nat Med 17, 437–438 (2011). https://doi.org/10.1038/nm0411-437
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0411-437
This article is cited by
-
After Conflicts of Interest: From Procedural Short-Cut to Ethico-Political Debate
Journal of Bioethical Inquiry (2020)
-
Debates about Conflict of Interest in Medicine: Deconstructing a Divided Discourse
Journal of Bioethical Inquiry (2017)
-
The Innovative Medicines Initiative: A European Response to the Innovation Challenge
Clinical Pharmacology & Therapeutics (2012)